Kanabo Group PLC
LSE:KNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Axcelis Technologies Inc
NASDAQ:ACLS
|
US |
|
Ambuja Cements Ltd
NSE:AMBUJACEM
|
IN |
|
NTR Holding A/S
CSE:NTR B
|
DK |
|
Shanxi Huhua Group Co Ltd
SZSE:003002
|
CN |
|
W
|
Western Metal Materials Co Ltd
SZSE:002149
|
CN |
Kanabo Group PLC
EPS (Diluted)
Kanabo Group PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kanabo Group PLC
LSE:KNB
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$6
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$2
|
CAGR 3-Years
37%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
EPS (Diluted)
£0
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kanabo Group PLC
Glance View
Kanabo Group Plc engages in the acquisition of a target company and business in the energy and industrial sectors. The firm is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. The company has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod, which is a vaporization delivery system for cannabis extract. The firm's R&D lab is set up in the Weizmann Science Park. The firm's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The firm is selling its initial products in Europe. The company is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.
See Also
What is Kanabo Group PLC's EPS (Diluted)?
EPS (Diluted)
-0
GBP
Based on the financial report for Dec 31, 2023, Kanabo Group PLC's EPS (Diluted) amounts to -0 GBP.
What is Kanabo Group PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
0%
Over the last year, the EPS (Diluted) growth was 50%.
